Human cytomegalovirus 65 kDa Phosphoprotein Market Report

China Human cytomegalovirus 65 kDa Phosphoprotein Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：186
  • REPORT CODE：GMM1786990
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Human cytomegalovirus 65 kDa Phosphoprotein industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Astellas Pharma Inc

    • Vakzine Projekt Management GmbH

    • VBI Vaccines Inc

    • Vaximm AG

    • Hookipa Biotech AG

    • Immunomic Therapeutics Inc

    By Type:

    • CyMVectin

    • Others

    • HB-101

    • PepVax

    • ASP-0113

    By Application:

    • Kidney Transplant Rejection

    • Others

    • Liver Transplant Rejection

    • Brain Tumor

    • Hemotaological Tumor

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Human cytomegalovirus 65 kDa Phosphoprotein Market Overview 2018-2029

    • 1.1 China Human cytomegalovirus 65 kDa Phosphoprotein Industry Development Overview

    • 1.2 China Human cytomegalovirus 65 kDa Phosphoprotein Industry Development History

    • 1.3 China Human cytomegalovirus 65 kDa Phosphoprotein Industry Market Size (2018-2029)

    • 1.4 China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis by Type from Production Side

      • 1.4.1 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of CyMVectin (2018-2029)

      • 1.4.2 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of HB-101 (2018-2029)

      • 1.4.4 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of PepVax (2018-2029)

      • 1.4.5 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of ASP-0113 (2018-2029)

    • 1.5 China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis by Application from Consumption End

      • 1.5.1 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Kidney Transplant Rejection (2018-2029)

      • 1.5.2 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Liver Transplant Rejection (2018-2029)

      • 1.5.4 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Brain Tumor (2018-2029)

      • 1.5.5 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Hemotaological Tumor (2018-2029)

    • 1.6 China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis by Region

      • 1.6.1 North China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    Chapter 2 China Human cytomegalovirus 65 kDa Phosphoprotein Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Human cytomegalovirus 65 kDa Phosphoprotein Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Human cytomegalovirus 65 kDa Phosphoprotein Market Status and Competition Analysis in 2023

      • 2.2.3 China Human cytomegalovirus 65 kDa Phosphoprotein Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Human cytomegalovirus 65 kDa Phosphoprotein Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Human cytomegalovirus 65 kDa Phosphoprotein Industry Development

    Chapter 3 Human cytomegalovirus 65 kDa PhosphoproteinIndustry Chain Analysis

    • 3.1 Human cytomegalovirus 65 kDa Phosphoprotein Industry Chain

    • 3.2 Human cytomegalovirus 65 kDa Phosphoprotein Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Human cytomegalovirus 65 kDa Phosphoprotein Market

    • 3.3 Human cytomegalovirus 65 kDa Phosphoprotein Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Human cytomegalovirus 65 kDa Phosphoprotein Market

    Chapter 4 China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 4.1 China Human cytomegalovirus 65 kDa Phosphoprotein Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Human cytomegalovirus 65 kDa Phosphoprotein Total Production Volume and Growth Rate from Production Side

    • 4.5 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate, by Type

      • 4.5.1 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of CyMVectin

      • 4.5.2 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of Others

      • 4.5.3 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of HB-101

      • 4.5.4 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of PepVax

      • 4.5.5 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of ASP-0113

    Chapter 5 China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Human cytomegalovirus 65 kDa Phosphoprotein Total Market Size and Growth Rate from Consumption End

    • 5.5 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate, by Application

      • 5.5.1 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Kidney Transplant Rejection

      • 5.5.2 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Others

      • 5.5.3 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Liver Transplant Rejection

      • 5.5.4 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Brain Tumor

      • 5.5.5 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Hemotaological Tumor

    Chapter 6 China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Region

    • 6.1 China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Production Value, by Region

    • 6.2 China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume and Sales Value, by Region

    Chapter 7 North China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis

    • 7.1 North China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 7.2 North China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    Chapter 8 Central China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis

    • 8.1 Central China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 8.2 Central China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    Chapter 9 South China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis

    • 9.1 South China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 9.2 South China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    Chapter 10 East China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis

    • 10.1 East China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 10.2 East China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    Chapter 11 Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis

    • 11.1 Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 11.2 Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    Chapter 12 Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis

    • 12.1 Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 12.2 Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    Chapter 13 Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Market Analysis

    • 13.1 Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Type

    • 13.2 Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Astellas Pharma Inc

        • 14.1.1 Astellas Pharma Inc Company Profile

        • 14.1.2 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Vakzine Projekt Management GmbH

        • 14.2.1 Vakzine Projekt Management GmbH Company Profile

        • 14.2.2 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 VBI Vaccines Inc

        • 14.3.1 VBI Vaccines Inc Company Profile

        • 14.3.2 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Vaximm AG

        • 14.4.1 Vaximm AG Company Profile

        • 14.4.2 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hookipa Biotech AG

        • 14.5.1 Hookipa Biotech AG Company Profile

        • 14.5.2 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Immunomic Therapeutics Inc

        • 14.6.1 Immunomic Therapeutics Inc Company Profile

        • 14.6.2 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Human cytomegalovirus 65 kDa Phosphoprotein Industry Research Conclusions

    • 15.2 Human cytomegalovirus 65 kDa Phosphoprotein Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Industry Market Size (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of CyMVectin (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of HB-101 (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of PepVax (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume, Production Value and Growth Rate of ASP-0113 (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Kidney Transplant Rejection (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Liver Transplant Rejection (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Brain Tumor (2018-2029)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume, Sales Value and Growth Rate of Hemotaological Tumor (2018-2029)

    • Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    • Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    • Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    • Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate from 2018-2029

    • Figure Human cytomegalovirus 65 kDa Phosphoprotein Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Type in 2018

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Type in 2023

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of CyMVectin (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of HB-101 (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of PepVax (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume and Growth Rate of ASP-0113 (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application in 2018

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application in 2023

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Total Market Size and Growth Rate from Consumption End

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Kidney Transplant Rejection (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Others (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Liver Transplant Rejection (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Brain Tumor (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Hemotaological Tumor (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Region (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Region (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Region (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Production Value by Region (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Production Value Share by Region (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Value Share by Region (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Region (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Region (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Region (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Value by Region (2018-2023)

    • Table China Human cytomegalovirus 65 kDa Phosphoprotein Sales Value Share by Region (2018-2023)

    • Figure China Human cytomegalovirus 65 kDa Phosphoprotein Sales Value Share by Region (2018-2023)

    • Table North China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Type (2018-2023)

    • Table North China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Table North China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Application (2018-2023)

    • Table North China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Type (2018-2023)

    • Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Application (2018-2023)

    • Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Table South China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Type (2018-2023)

    • Table South China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Table South China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Application (2018-2023)

    • Table South China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Table East China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Type (2018-2023)

    • Table East China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Table East China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Application (2018-2023)

    • Table East China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Type (2018-2023)

    • Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Application (2018-2023)

    • Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Type (2018-2023)

    • Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Application (2018-2023)

    • Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume by Type (2018-2023)

    • Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Production Volume Share by Type (2018-2023)

    • Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume by Application (2018-2023)

    • Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Share by Application (2018-2023)

    • Table Astellas Pharma Inc Company Profile

    • Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue, Price and Gross (2018-2023)

    • Table Vakzine Projekt Management GmbH Company Profile

    • Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Revenue, Price and Gross (2018-2023)

    • Table VBI Vaccines Inc Company Profile

    • Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue, Price and Gross (2018-2023)

    • Table Vaximm AG Company Profile

    • Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue, Price and Gross (2018-2023)

    • Table Hookipa Biotech AG Company Profile

    • Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue, Price and Gross (2018-2023)

    • Table Immunomic Therapeutics Inc Company Profile

    • Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US